Progress towards mechanism-based treatment for diamond-Blackfan anemia

The Scientific World Journal

Volumn 2012, Issue , 2012, Pages

  Sjgren, Sara E ^a   Flygare, Johan ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; DEFERASIROX; DEFLAZACORT; ERYTHROPOIETIN; GLUCOCORTICOID; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN G; INTERLEUKIN 3; LENALIDOMIDE; LEUCINE; METOCLOPRAMIDE; PREDNISONE; PROTEIN P53; RIBOSOME PROTEIN; RIBOSOME PROTEIN S19; UNCLASSIFIED DRUG; VALPROIC ACID;

5Q- SYNDROME; ANTICONVULSANT THERAPY; APOPTOSIS; BLACKFAN DIAMOND ANEMIA; BONE MARROW DEPRESSION; CATARACT; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL RENEWAL; CELL SURVIVAL; CLINICAL TRIAL (TOPIC); COLONY FORMING UNIT E; CORTICOSTEROID THERAPY; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; DRUG WITHDRAWAL; DUCHENNE MUSCULAR DYSTROPHY; ERYTHROPOIESIS; FRACTURE; GENE MUTATION; GROWTH RETARDATION; HUMAN; HYPERTENSION; INFECTION; MANDIBULOFACIAL DYSOSTOSIS; MOLECULAR PATHOLOGY; MYELODYSPLASTIC SYNDROME; NONHUMAN; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; REMISSION; REVIEW; SEIZURE; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; VIRAL GENE THERAPY;

EID: 84861064000     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/2012/184362     Document Type: Review

References (84)

1. Nathan D. G., Clarke B. J., Hillman D. G., Alter B. P., Housman D. E., Erythroid precursors in congenital hypoplastic (Diamond-Blackfan) anemia Journal of Clinical Investigation 1978 61 2 489 498 (Pubitemid 8280420)
2. Diamond L. K., Blackfan K. D., Hypoplastic anemia American Journal of Diseases of Children 1938 56 464 467
3. Vlachos A., Muir E., How I treat Diamond-Blackfan anemia Blood 2010 116 19 3715 3723
4. Vlachos A., Ball S., Dahl N., Alter B. P., Sheth S., Ramenghi U., Meerpohl J., Karlsson S., Liu J. M., Leblanc T., Paley C., Kang E. M., Leder E. J., Atsidaftos E., Shimamura A., Bessler M., Glader B., Lipton J. M., Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference British Journal of Haematology 2008 142 6 859 876
5. Glader B. E., Backer K., Elevated red cell adenosine deaminase activity: a marker of disordered erythropiesis in Diamond-Blackfan anaemia and other haematologic diseases British Journal of Haematology 1988 68 2 165 168 (Pubitemid 18078461)
6. Lipton J. M., Atsidaftos E., Zyskind I., Vlachos A., Improving clinical care and elucidating the pathophysiology of Diamond Blackfan anemia: an update from the Diamond Blackfan Anemia Registry Pediatric Blood and Cancer 2006 46 5 558 564
7. Willig T. N., Niemeyer C. M., Leblanc T., Identification of new prognosis factors from the clinical and epidemiologic analysis of a registry of 229 Diamond-Blackfan anemia patients. DBA group of Societe d'Hematologie et d'Immunologie Pediatrique (SHIP), Gesellshaft fur Padiatrische Onkologie und Hamatologie (GPOH), and the European Society for Pediatric Hematology and Immunology (ESPHI) Pediatric Research 1999 46 5 553 561
8. Roy V., Perez W. S., Eapen M., Marsh J. C., Pasquini M., Pasquini R., Mustafa M. M., Bredeson C. N., Bone marrow transplantation for Diamond-Blackfan anemia Biology of Blood and Marrow Transplantation 2005 11 8 600 608 (Pubitemid 41001635)
9. Draptchinskaia N., Gustavsson P., Andersson B., Pettersson M., Willig T. N., Dianzani I., Ball S., Tchernia G., Klar J., Matsson H., Tentler D., Mohandas N., Carlsson B., Dahl N., The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia Nature Genetics 1999 21 2 169 175 (Pubitemid 29070361)
10. Cmejla R., Cmejlova J., Handrkova H., Petrak J., Pospisilova D., Ribosomal protein S17 gene (RPS17) is mutated in Diamond-Blackfan anemia Human Mutation 2007 28 12 1178 1182 (Pubitemid 350250381)
11. Doherty L., Sheen M. R., Vlachos A., Choesmel V., O'Donohue M. F., Clinton C., Schneider H. E., Sieff C. A., Newburger P. E., Ball S. E., Niewiadomska E., Matysiak M., Glader B., Arceci R. J., Farrar J. E., Atsidaftos E., Lipton J. M., Gleizes P. -E., Gazda H. T., Ribosomal protein genes RPS10 and RPS26 are commonly mutated in Diamond-Blackfan anemia American Journal of Human Genetics 2010 86 2 222 228
12. Farrar J. E., Nater M., Caywood E., McDevitt M. A., Kowalski J., Takemoto C. M., Talbot C. C. Jr., Meltzer P., Esposito D., Beggs A. H., Schneider H. E., Grabowska A., Ball S. E., Niewiadomska E., Sieff C. A., Vlachos A., Atsidaftos E., Ellis S. R., Lipton J. M., Gazda H. T., Arceci R. J., Abnormalities of the large ribosomal subunit protein, Rpl35a, in Diamond-Blaekfan anemia Blood 2008 112 5 1582 1592
13. Gazda H. T., Grabowska A., Merida-Long L. B., Latawiec E., Schneider H. E., Lipton J. M., Vlachos A., Atsidaftos E., Ball S. E., Orfali K. A., Niewiadomska E., Da Costa L., Tchernia G., Niemeyer C., Meerpohl J. J., Stahl J., Schratt G., Glader B., Backer K., Wong C., Nathan D. G., Beggs A. H., Sieff C. A., Ribosomal protein S24 gene is mutated in Diamond-Blackfan anemia American Journal of Human Genetics 2006 79 6 1110 1118 (Pubitemid 44868071)
14. Gazda H. T., Sheen M. R., Vlachos A., Choesmel V., O'Donohue M. F., Schneider H., Darras N., Hasman C., Sieff C. A., Newburger P. E., Ball S. E., Niewiadomska E., Matysiak M., Zaucha J. M., Glader B., Niemeyer C., Meerpohl J. J., Atsidaftos E., Lipton J. M., Gleizes P. E., Beggs A. H., Ribosomal protein L5 and L11 mutations are associated with cleft palate and abnormal thumbs in Diamond-Blackfan anemia patients American Journal of Human Genetics 2008 83 6 769 780
15. Boria I., Garelli E., Gazda H. T., Aspesi A., Quarello P., Pavesi E., Ferrante D., Meerpohl J. J., Kartal M., Da Costa L., Proust A., Leblanc T., Simansour M., Dahl N., Frojmark A. S., Pospisilova D., Cmejla R., Beggs A. H., Sheen M. R., Landowski M., Buros C. M., Clinton C. M., Dobson L. J., Vlachos A., Atsidaftos E., Lipton J. M., Ellis S. R., Ramenghi U., Dianzani I., The ribosomal basis of Diamond-Blackfan anemia: mutation and database update Human Mutation 2010 31 12 1269 1279
16. Hamaguchi I., Ooka A., Brun A., Richter J., Dahl N., Karlsson S., Gene transfer improves erythroid development in ribosomal protein S19-deficient Diamond-Blackfan anemia Blood 2002 100 8 2724 2731
17. Hamaguchi I., Flygare J., Nishiura H., Brun A. C., Ooka A., Kiefer T., Ma Z., Dahl N., Richter J., Karlsson S., Proliferation deficiency of multipotent hematopoietic progenitors in ribosomal protein S19 (RPS19)-deficient Diamond-Blackfan anemia improves following RPS19 gene transfer Molecular Therapy 2003 7 5 613 622 (Pubitemid 36626241)
18. Flygare J., Olsson K., Richter J., Karlsson S., Gene therapy of Diamond Blackfan anemia CD34(+) cells leads to improved erythroid development and engraftment following transplantation Experimental Hematology 2008 36 11 1428 1435
19. Flygare J., Kiefer T., Miyake K., Utsugisawa T., Hamaguchi I., Da Costa L., Richter J., Davey E. J., Matsson H., Dahl N., Wiznerowicz M., Trono D., Karlsson S., Deficiency of ribosomal protein S19 in CD34+ cells generated by siRNA blocks erythroid development and mimics defects seen in Diamond-Blackfan anemia Blood 2005 105 12 4627 4634 (Pubitemid 40807281)
20. Ebert B. L., Lee M. M., Pretz J. L., Subramanian A., Mak R., Golub T. R., Sieff C. A., An RNA interference model of RPS19 deficiency in Diamond-Blackfan anemia recapitulates defective hematopoiesis and rescue by dexamethasone: identification of dexamethasone-responsive genes by microarray Blood 2005 105 12 4620 4626 (Pubitemid 40807280)
21. Sieff C. A., Yang J., Merida-Long L. B., Lodish H. F., Pathogenesis of the erythroid failure in Diamond Blackfan anaemia British Journal of Haematology 2010 148 4 611 622
22. Jaako P., Flygare J., Olsson K., Quere R., Larsson J., Bryder D., Karlsson S., Chronic RPS19 deficiency leads to bone marrow failure in a mouse model for Diamond Blackfan anemia Proceedings of the 52nd Annual Meeting of the American-Society-of-Hematology (ASH '10) 2010 Orlando, Fla, USA The American Society of Hematology 116 193
23. Ohene-Abuakwa Y., Orfali K. A., Marius C., Ball S. E., Two-phase culture in Diamond Blackfan anemia: localization of erythroid defect Blood 2005 105 2 838 846 (Pubitemid 40070773)
24. Miyake K., Utsugisawa T., Flygare J., Kiefer T., Hamaguchi I., Richter J., Karlsson S., Ribosomal protein S19 deficiency leads to reduced proliferation and increased apoptosis but does not affect terminal erythroid differentiation in a cell line model of Diamond-Blackfan anemia Stem Cells 2008 26 2 323 329 (Pubitemid 351413591)
25. Jones N. C., Lynn M. L., Gaudenz K., Sakai D., Aoto K., Rey J. P., Glynn E. F., Ellington L., Du C., Dixon J., Dixon M. J., Trainor P. A., Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 function Nature Medicine 2008 14 2 125 133 (Pubitemid 351214559)
26. Dutt S., Narla A., Lin K., Mullally A., Abayasekara N., Megerdichian C., Wilson F. H., Currie T., Khanna-Gupta A., Berliner N., Kutok J. L., Ebert B. L., Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells Blood 2011 117 9 2567 2576
27. Barlow J. L., Drynan L. F., Hewett D. R., Holmes L. R., Lorenzo-Abalde S., Lane A. L., Jolin H. E., Pannell R., Middleton A. J., Wong S. H., Warren A. J., Wainscoat J. S., Boultwood J., McKenzie A. N., A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q-syndrome Nature Medicine 2010 16 1 59 66
28. Danilova N., Sakamoto K. M., Lin S., Ribosomal protein S19 deficiency in zebrafish leads to developmental abnormalities and defective erythropoiesis through activation of p53 protein family Blood 2008 112 13 5228 5237
29. Taylor A. M., Humphries J. M., White R. M., Murphey R. D., Burns C. E., Zon L. I., Hematopoietic defects in rps29 mutant zebrafish depend upon p53 activation Experimental Hematology 2012 40 3 228 237
30. Jaako P., Flygare J., Olsson K., Mice with ribosomal protein S19 deficiency develop bone marrow failure and symptoms like patients with Diamond-Blackfan anemia Blood 2011 118 23 6087 6096
31. Zhang Y., Wolf G. W., Bhat K., Jin A., Allio T., Burkhart W. A., Xiong Y., Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway Molecular and Cellular Biology 2003 23 23 8902 8912 (Pubitemid 37433388)
32. Dai M. S., Lu H., Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5 The Journal of Biological Chemistry 2004 279 43 44475 44482 (Pubitemid 39430853)
33. Takagi M., Absalon M. J., McLure K. G., Kastan M. B., Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin Cell 2005 123 1 49 63 (Pubitemid 41414528)
34. Miliani de Marval P. L., Zhang Y., The RP-Mdm2-p53 pathway and tumorigenesis Oncotarget 2011 2 3 234 238
35. Fumagalli S., Di Cara A., Neb-Gulati A., Natt F., Schwemberger S., Hall J., Babcock G. F., Bernardi R., Pandolfi P. P., Thomas G., Absence of nucleolar disruption after impairment of 40S ribosome biogenesis reveals an rpL11-translationdependent mechanism of p53 induction Nature Cell Biology 2009 11 4 501 508
36. McGowan K. A., Li J. Z., Park C. Y., Beaudry V., Tabor H. K., Sabnis A. J., Zhang W., Fuchs H., de Angelis M. H., Myers R. M., Attardi L. D., Barsh G. S., Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects Nature Genetics 2008 40 8 963 970
37. Gasser C., Aplastic anemia (chronic erythroblastophthisis) and cortisone Schweizerische Medizinische Wochenschrift 1951 81 50 1241 1242
38. Calvert R. J., Robson T., Cortisone therapy in erythrogenesis imperfecta Archives of Disease in Childhood 1956 31 157 177 181
39. Yeh T. F., Lin Y. J., Hsieh W. S., Lin H. C., Lin C. H., Chen J. Y., Kao H. A., Chien C. H., Early postnatal dexamethasone therapy for the prevention of chronic lung disease in preterm infants with respiratory distress syndrome: a multicenter clinical trial Pediatrics 1997 100 4, article E3
40. Yeh T. F., Lin Y. J., Huang C. C., Chen Y. J., Lin C. H., Lin H. C., Hsieh W. S., Lien Y. J., Early dexamethasone therapy in preterm infants: a follow-up study Pediatrics 1998 101 5 E7
41. Narla A., Dutt S., McAuley J. R., Al-Shahrour F., Hurst S., McConkey M., Neuberg D., Ebert B. L., Dexamethasone and lenalidomide have distinct functional effects on erythropoiesis Blood 2011 118 8 2296 2304
42. Flygare J., Estrada V. R., Shin C., Gupta S., Lodish H. F., HIF1 synergizes with glucocorticoids to promote BFU-E progenitor self-renewal Blood 2011 117 12 3435 3444
43. Lodish H., Flygare J., Chou S., From stem cell to erythroblast: regulation of red cell production at multiple levels by multiple hormones IUBMB Life 2010 62 7 492 496
44. Bauer A., Tronche F., Wessely O., Kellendonk C., Reichardt H. M., Steinlein P., Schutz G., Beug H., The glucocorticoid receptor is required for stress erythropoiesis Genes and Development 1999 13 22 2996 3002
45. Leberbauer C., Boulme F., Unfried G., Huber J., Beug H., Mullner E. W., Different steroids co-regulate long-term expansion versus terminal differentiation in primary human erythroid progenitors Blood 2005 105 1 85 94 (Pubitemid 40053068)
46. Wessely O., Deiner E. M., Beug H., von Lindern M., The glucocorticoid receptor is a key regulator of the decision between self-renewal and differentiation in erythroid progenitors The EMBO Journal 1997 16 2 267 280 (Pubitemid 27049385)
47. Ganguli G., Back J., Sengupta S., Wasylyk B., The p53 tumour suppressor inhibits glucocorticoid-induced proliferation of erythroid progenitors EMBO Reports 2002 3 6 569 574 (Pubitemid 34752458)
48. Leonard E. M., Raefsky E., Griffith P., Kimball J., Nienhuis A. W., Young N. S., Cyclosporine therapy of aplastic anaemia, congenital and acquired red cell aplasia British Journal of Haematology 1989 72 2 278 284 (Pubitemid 19151153)
49. El-Beshlawy A., Ibrahim I. Y., Rizk S., Eid K., Study of 22 Egyptian patients with Diamond-Blackfan anemia, corticosteroids, and cyclosporin therapy results Pediatrics 2002 110 4 e44
50. Seip M., Zanussi G. F., Cyclosporine in steroid-resistant Diamond-Blackfan anaemia Acta Paediatrica Scandinavica 1988 77 3 464 466
51. Taher A. T., Musallam K. M., Koussa S., Inati A., Transfusion independence in Diamond-Blackfan anemia after deferasirox therapy Annals of Hematology 2009 88 12 1263 1264
52. Fiorillo A., Poggi V., Migliorati R., Parasole R., Selleri C., Rotoli B., Letter to the editor: unresponsiveness to erythropoietin therapy in a case of Blackfan Diamond anemia American Journal of Hematology 1991 37 1 65
53. Niemeyer C. M., Baumgarten E., Holldack J., Meier I., Trenn G., Jobke A., Eckhardt K. U., Reiter A., Sauter S., Riehm H., Treatment trial with recombinant human erythropoietin in children with congenital hypoplastic anemia Contributions to Nephrology 1991 88 276 280
54. Bastion Y., Bordigoni P., Debre M., Girault D., Leblanc T., Tchernia G., Ball S., McGuckin C., Gordon-Smith E. C., Bekassy A., Elinder G., Wranne L., Sustained response after recombinant interleukin-3 in Diamond Blackfan anemia Blood 1994 83 2 617 618 (Pubitemid 24030593)
55. Ganser A., Lindemann A., Seipelt G., Ottmann O. G., Eder M., Falk S., Herrmann F., Kaltwasser J. P., Meusers P., Klausmann M., Frisch J., Schulz G., Mertelsmann R., Hoelzer D., Effects of recombinant human interleukin-3 in aplastic anemia Blood 1990 76 7 1287 1292 (Pubitemid 20342741)
56. Gillio A. P., Faulkner L. B., Alter B. P., Reilly L., Klafter R., Heller G., Young D. C., Lipton J. M., Moore M. A., O'Reilly R. J., Treatment of Diamond-Blackfan anemia with recombinant human interleukin-3 Blood 1993 82 3 744 751 (Pubitemid 23221652)
57. Ball S. E., Tchernia G., Wranne L., Bastion Y., Bekassy N. A., Bordigoni P., Debre M., Elinder G., Kamps W. A., Lanning M., Leblanc T., Makipernaa A., Is there a role for interleukin-3 in Diamond-Blackfan anaemia? Results of a European multicentre study British Journal of Haematology 1995 91 2 313 318
58. Sumimoto S., Kawai M., Kasajima Y., Hamamoto T., Intravenous -globulin therapy in Diamond-Blackfan anemia Acta Paediatrica Japonica (Overseas Edition) 1992 34 2 179 180
59. Sopo S. M., Pesaresi M. A., Pastore M., Stabile A., Intravenous immunoglobulin in Diamond-Blackfan anaemia European Journal of Pediatrics 1990 149 11 779 780 (Pubitemid 20290954)
60. Abkowitz J. L., Schaison G., Boulad F., Brown D. L., Buchanan G. R., Johnson C. A., Murray J. C., Sabo K. M., Response of Diamond-Blackfan anemia to metoclopramide: evidence for a role for prolactin in erythropoiesis Blood 2002 100 8 2687 2691
61. Leblanc T. M., Da Costa L., Marie I., Demolis P., Tchernia G., Metoclopramide treatment in DBA patients: no complete response in a French prospective study Blood 2007 109 5 2266 2267 (Pubitemid 46348236)
62. Jabr F. I., Aoun E., Azar C., Taher A., Diamond-Blackfan anemia responding to valproic acid Blood 2004 104 10 3415 (Pubitemid 39507171)
63. Koury M. J., Bondurant M. C., Maintenance by erythropoietin of viability and maturation of murine erythroid precursor cells Journal of Cellular Physiology 1988 137 1 65 74
64. Eshghi S., Vogelezang M. G., Hynes R. O., Griffith L. G., Lodish H. F., 4 1 integrin and erythropoietin mediate temporally distinct steps in erythropoiesis: integrins in red cell development Journal of Cell Biology 2007 177 5 871 880 (Pubitemid 46873092)
65. Wu H., Liu X., Jaenisch R., Lodish H. F., Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor Cell 1995 83 1 59 67
66. Chan H. S., Saunders E. F., Freedman M. H., Diamond-Blackfan syndromeI. Erythropoiesis in prednisone responsive and resistant disease Pediatric Research 1982 16 6 474 476 (Pubitemid 12117222)
67. Reddy E. P., Korapati A., Chaturvedi P., Rane S., IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled Oncogene 2000 19 21 2532 2547 (Pubitemid 30339209)
68. Rinaudo M. S., Su K., Falk L. A., Haldar S., Mufson R. A., Human interleukin-3 receptor modulates bcl-2 mRNA and protein levels through protein kinase C in TF-1 cells Blood 1995 86 1 80 88
69. Uo T., Veenstra T. D., Morrison R. S., Histone deacetylase inhibitors prevent p53-dependent and p53-independent bax-mediated neuronal apoptosis through two distinct mechanisms Journal of Neuroscience 2009 29 9 2824 2832
70. Naithani R., Chandra J., Narayan S., Singh V., Dutta A. K., Diamond-Blackfan anemia: clinical features and treatment results in 4 cases Hematology 2006 11 3 193 195 (Pubitemid 44355701)
71. Broudy V. C., Stem cell factor and hematopoiesis Blood 1997 90 4 1345 1364 (Pubitemid 27355406)
72. List A., Dewald G., Bennett J., Giagounidis A., Raza A., Feldman E., Powell B., Greenberg P., Thomas D., Stone R., Reeder C., Wride K., Patin J., Schmidt M., Zeldis J., Knight R., Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion The New England Journal of Medicine 2006 355 14 1456 1465 (Pubitemid 44511560)
73. Ebert B. L., Pretz J., Bosco J., Chang C. Y., Tamayo P., Galili N., Raza A., Root D. E., Attar E., Ellis S. R., Golub T. R., Identification of RPS14 as a 5q-syndrome gene by RNA interference screen Nature 2008 451 7176 335 339
74. Lee M. Y., Jo S. D., Lee J. H., Han H. J., L-leucine increases [ 3 H]-thymidine incorporation in chicken hepatocytes: involvement of the PKC, PI3K/Akt, ERK1/2, and mTOR signaling pathways Journal of Cellular Biochemistry 2008 105 6 1410 1419
75. Singh G., Akcakanat A., Sharma C., Luyimbazi D., Naff K. A., Meric-Bernstam F., The effect of leucine restriction on Akt/mTOR signaling in breast cancer cell lines in vitro and in vivo Nutrition and Cancer 2011 63 2 264 271
76. Kimball S. R., Jefferson L. S., Signaling pathways and molecular mechanisms through which branched-chain amino acids mediate translational control of protein synthesis Journal of Nutrition 2006 136 Supplement 1 227S 231S (Pubitemid 43156513)
77. Cmejlova J., Dolezalova L., Pospisilova D., Petrtylova K., Petrak J., Cmejla R., Translational efficiency in patients with Diamond-Blackfan anemia Haematologica 2006 91 11 1456 1464 (Pubitemid 44736111)
78. Pospisilova D., Cmejlova J., Hak J., Adam T., Cmejla R., Successful treatment of a Diamond-Blackfan anemia patient with amino acid leucine Haematologica 2007 92 5 e66 e67
79. Jaako P., Debnath S., Olsson K., Flygare J., Karlsson S., Bone marrow failure in RPS19-deficient mice is partly caused by p53 activation and responds to L-Leucine treatment Proceedings of the 53nd Annual Meeting of the American-Society-of-Hematology (ASH '11) 2011 San Diego, Calif, USA The American Society of Hematology 118 727
80. Soker M., Ayyildiz O., Isikdogan A., Aase-Smith syndrome type II Saudi Medical Journal 2004 25 12 2004 2006 (Pubitemid 40253687)
81. Messa E., Cilloni D., Messa F., Arruga F., Roetto A., Saglio G., Deferasirox treatment improved the hemoglobin level and decreased transfusion requirements in four patients with the myelodysplastic syndrome and primary myelofibrosis Acta Haematologica 2008 120 2 70 74
82. Wang G. L., Semenza G. L., Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction Blood 1993 82 12 3610 3615 (Pubitemid 24006041)
83. Saletta F., Rahmanto Y. S., Noulsri E., Richardson D. R., Iron chelator-mediated alterations in gene expression: identification of novel iron-regulated molecules that are molecular targets of hypoxia-inducible factor-1 and p53 Molecular Pharmacology 2010 77 3 443 458
84. Russ A. P., Lampel S., The druggable genome: an update Drug Discovery Today 2005 10 23-24 1607 1610 (Pubitemid 41817609)